SCHEMBL572903

SCHEMBL572903

COC(=O)c1cc(N)c(Cl)c(S(=O)(=O)N=CN(C)C)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.38
▸ ALDH1A1 P00352 5/20 0.38
▸ GAA P10253 5/20 0.38
▸ HPGD P15428 4/20 0.38
▸ PKM P14618 1/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ MAPT P10636 2/20 0.37
▸ GLA P06280 1/20 0.37
▸ CASP1 P29466 1/20 0.37
▸ CASP7 P55210 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ USP2 O75604 1/20 0.35
▸ L3MBTL1 Q9Y468 3/20 0.35
▸ LMNA P02545 3/20 0.35
▸ NPSR1 Q6W5P4 2/20 0.35
▸ ABL1 P00519 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL572902 1.00 KDM4E (0.38) KDM4EALDH1A1GAAHPGDPKM
SCHEMBL10224339 0.86 SMN1; SMN2 (0.38) KDM4EALDH1A1GAAHPGDSMN1; SMN2
SCHEMBL573292 0.82 VCAM1 (0.47) KDM4EALDH1A1HPGDPKMSMN1; SMN2
SCHEMBL573293 0.82 VCAM1 (0.47) KDM4EALDH1A1HPGDPKMSMN1; SMN2
SCHEMBL11512665 0.82 ALDH1A1 (0.39) KDM4EALDH1A1GAAHPGDPKM
SCHEMBL574219 0.81 HPGD (0.45) KDM4EALDH1A1GAAHPGDPKM
SCHEMBL574218 0.81 HPGD (0.45) KDM4EALDH1A1GAAHPGDPKM
SCHEMBL11542934 0.80 SMN1; SMN2 (0.56) ALDH1A1GAAHPGDSMN1; SMN2CYP1A2
SCHEMBL10996371 0.80 GAA (0.43) KDM4EALDH1A1GAAHPGDPKM
SCHEMBL10996368 0.80 GAA (0.43) KDM4EALDH1A1GAAHPGDPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2598478-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE Neurotherapeutics Pharma, Inc. (US) 2013-06-05 — — EP disclosed
WO-2012018635-A2 ARYLSULFONAMIDE DERIVATIVES, COMPOSITIONS, AND METHODS OF USE NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-02-09 — — WO disclosed
Send feedback